Literature DB >> 6325122

Characterization and localization of vasoactive intestinal peptide receptors in the rat lung.

P Leroux, H Vaudry, A Fournier, S St-Pierre, G Pelletier.   

Abstract

Experiments were performed to characterize vasoactive intestinal peptide (VIP) receptors in rat lung and to study their localization by means of light and electron microscope autoradiography. [125I]Iodo-VIP binding to lung homogenate was inhibited by synthetic VIP, [Val5]secretin, secretin, and 7-27 secretin with half-maximal inhibition (ID50) values of 1.62, 13, 121 nmol/liter and up to 0.1 mmol/liter, respectively. The relative potency of [Val5]secretin and 7-27 secretin to displace the tracer indicated that [125I]iodo-VIP binds to specific VIP receptors. Kinetic studies showed two sites of binding, a site of high affinity with equilibrium dissociation constant (KD) values of 0.32 +/- 0.09 nM and Bmax of 88.7 +/- 28.6 fmol/mg protein and a lower affinity binding site with a KD value of 23.0 +/- 2.9 mM and Bmax of 584 +/- 136.9 fmol/mg protein. The localization of VIP receptors was performed by radioautography both in vivo after iv injection of [125I]iodo-VIP and in vitro by the direct application of the radiolabeled peptide to cryostat sections of unfixed lung tissue. After iv injection of label, silver grains were detected only over alveoli. Electron microscopy indicated that radioactivity was mostly associated with alveolar capillaries. In vitro localization studies showed specific binding not only to alveoli but also to bronchi. These studies suggest that VIP can act at different sites and that the peptide could gain access to alveoli via the general circulation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325122     DOI: 10.1210/endo-114-5-1506

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Role of vasoactive intestinal peptide in hyperoxia-induced injury of primary type II alveolar epithelial cells.

Authors:  Xiaoxiao Ao; Fang Fang; Feng Xu
Journal:  Indian J Pediatr       Date:  2010-10-07       Impact factor: 1.967

2.  Regulatory peptides in the respiratory system.

Authors:  P J Barnes
Journal:  Experientia       Date:  1987-07-15

3.  Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

Authors:  U Bickel; T Yoshikawa; E M Landaw; K F Faull; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

4.  Neuroregulation by vasoactive intestinal peptide (VIP) of mucus secretion in ferret trachea: activation of BK(Ca) channels and inhibition of neurotransmitter release.

Authors:  Y C Liu; H J Patel; A M Khawaja; M G Belvisi; D F Rogers
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

5.  A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.

Authors:  T W Moody; F Zia; M Draoui; D E Brenneman; M Fridkin; A Davidson; I Gozes
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.